Alphapharm loses bid for docs in Sanofi injector pen patent dispute

Christian Dimitriadis 2018-10-30 11:47 pm By Cat Fredenburgh | Melbourne

Please login to bookmark

Generic drug maker Alphapharm has lost another bid for documents from Sanofi-Aventis in advance of a hearing on Sanofi’s interlocutory application seeking to block the generic drug maker from listing its injector pen on the Pharmaceutical Benefits Scheme.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au